Prestige Brands (PBH)
Prestige Brands Revenues: 134.00M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PBH Revenues Rankings
| Overall | 53rd percentile | 2079 of 4432 |
| Sector | 71st percentile | 134 of 471 in Healthcare |
| Industry | 60th percentile | 4 of 10 in Drug Related Products |
PBH Revenues Range, Past 5 Years
| Minimum | 57.31M | Mar 2009 |
| Maximum | 134.00M | Mar 2012 |
| Average | 83.98M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these PBH related companies
PBH News
$PBH filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3zCV
about 6 days ago by MarketBrief
about 6 days ago by MarketBrief
UPDATE: Oppenheimer Upgrades Prestige Brands Holdings to Outperform; Balance Sheet Deleveraging
May 18, 8:07AM Benzinga
May 18, 8:07AM Benzinga
News related to $PBH, currently +0.0% since open: 'Prestige Brands posts small fiscal 4Q loss' http://stks.co/3sA8
about 14 days ago by TradeBot
about 14 days ago by TradeBot
Listen to $PBH Q4 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3rwf
about 14 days ago by earningscast
about 14 days ago by earningscast
Market Wrap Video + Additions to Watch List http://stks.co/3p31 including: $GPRN $VRTX $PBH $CNQR $INSP $CIEN $GILD
about 17 days ago by StockTiger
about 17 days ago by StockTiger
Prestige Brands Holdings, Inc. to Release Fiscal 2012 Fourth Quarter & Year-End Earnings on May 17th
May 07, 4:44PM Business Wire
May 07, 4:44PM Business Wire
Prestige Brands (PBH) Responds to Genomma Lab's Withdrawal of Bid: Says Still Open to Considering Offers
May 03, 2:18PM Street Insider
May 03, 2:18PM Street Insider
Prestige Brands Comments on Genomma Lab's Withdrawal of its Acquisition Proposal
May 03, 2:03PM Benzinga
May 03, 2:03PM Benzinga
Prestige Brands Comments on Genomma Lab’s Withdrawal of its Acquisition Proposal
May 03, 2:03PM Business Wire
May 03, 2:03PM Business Wire
UPDATE: Genomma Lab Will Proceed to Terminate Financing for Prestige Brands Deal
May 03, 11:04AM Benzinga
May 03, 11:04AM Benzinga
Genomma Lab Internacional Announces Decision Not To Pursue Acquisition of Prestige Brands Holdings
May 03, 11:00AM PR Newswire
May 03, 11:00AM PR Newswire
Quant modell indicates a 2 - 1 chance for $PBH not closing below 13.73 today. Now trading at 13.87 or -15.5%
about 28 days ago by TradeBot
about 28 days ago by TradeBot
Prestige Brands Holdings, Inc. Completes Purchase of Debrox® and Gly-Oxide® from GSK Finalizing 17 Brand Transaction
Apr 02, 4:40PM Business Wire
Apr 02, 4:40PM Business Wire
$PBH Guides Q4 EPS $0.23 vs $0.22 Est; Q4 Revenue $133M vs $126.8M Est; FY13 EPS $1.22-1.32 vs $1.21 Est
about 70 days ago by Benzinga
about 70 days ago by Benzinga
Listen to $PBH Q3 2012 earnings call (EPS 0.19 vs est 0.25) - live at 08:30 AM, ondemand after - http://stks.co/2K56
about 112 days ago by earningscast
about 112 days ago by earningscast
$PBH 200 Day SMA Cross - Price crossed below 200 day SMA (11.0179). Confirmed by volume.
about 162 days ago by TradeIdeasQuant
about 162 days ago by TradeIdeasQuant
$GSK to sell 17 OTC brands in North America to $PBH for $660M; PBH shares up 7.8% pre-open
about 163 days ago by Street_Insider
about 163 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PBH | 13.72 | -0.01 | -0.07% | 692.40M |
| PBCT | 11.63 | +0.02 | +0.17% | 4.163B |
| PB | 42.69 | +0.22 | +0.52% | 2.006B |
| PAYX | 29.97 | -0.13 | -0.43% | 10.91B |
| PAY | 36.09 | -0.16 | -0.44% | 3.868B |
| PATR | 20.39 | -0.73 | -3.46% | 189.83M |
| ORBC | 3.29 | +0.06 | +1.86% | 150.03M |
| ORB | 11.19 | -0.12 | -1.06% | 666.61M |
| ORA | 20.31 | +0.20 | +0.99% | 913.60M |
| OPY | 14.00 | +0.03 | +0.21% | 189.85M |
